BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//IS2M - ECPv6.15.14//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:IS2M
X-ORIGINAL-URL:https://www.is2m.uha.fr
X-WR-CALDESC:Évènements pour IS2M
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20270328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20271031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20260106T090000
DTEND;TZID=Europe/Paris:20260106T100000
DTSTAMP:20260426T090420
CREATED:20251222T074834Z
LAST-MODIFIED:20251222T074834Z
UID:14406-1767690000-1767693600@www.is2m.uha.fr
SUMMARY:Porous Silicon and Quantum Dots: A Tunable Platform for Engineering Polaritons  
DESCRIPTION:Jean-François Bryche (researcher) and Vincent Forster (PhD student) from the Laboratoire Nanotechnologies et Nanosystèmes (LN2 -Sherbrooke\, Canada) will present their respective research topics. \nLink to abstract
URL:https://www.is2m.uha.fr/event/porous-silicon-and-quantum-dots-a-tunable-platform-for-engineering-polaritons/
LOCATION:Amphithéâtre de l’IS2M\, 15 rue jean starcky\, Mulhouse\, Mulhouse\, 68057\, France
ATTACH;FMTTYPE=image/png:https://www.is2m.uha.fr/wp-content/uploads/2025/12/seminaire-bryche.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20260109T100000
DTEND;TZID=Europe/Paris:20260109T110000
DTSTAMP:20260426T090421
CREATED:20260106T072429Z
LAST-MODIFIED:20260107T073827Z
UID:14410-1767952800-1767956400@www.is2m.uha.fr
SUMMARY:Romain Barbet: Institut de Recherche en Hématologie et Transplantation (Mulhouse)
DESCRIPTION:Romain Barbet is coming to visit us on January 9th. He is the head of the IRHT (Institut de Recherche en Hématologie et Transplantation) in Mulhouse.\nHe will present an overview of their current research and the tools they are developing.\nBelow is a short description of the IRHT. \nThe IRHT in Mulhouse is an independent biomedical research institute located inside Hasenrain Hospital and dedicated to hematology\, transplantation and cancer research\, with a long‑standing expertise in stem cells.  It was founded in 1987 by hematologist Philippe Hénon and is managed as a non‑profit association recognized as being of public interest\, with a small permanent team and many national and international collaborations.[1][2][3][4][5][6][7] \n## Mission and general focus \nIRHT’s overall goal is to develop new cell‑based therapies for blood diseases\, cancers and severe tissue damage\, particularly of the heart\, using stem cells and transplantation approaches.  The institute combines fundamental research on stem cell biology with translational and clinical projects\, so that discoveries in the lab can be tested and eventually used in patients from the surrounding region.[2][3][8][6][9][10] \n## Adult and blood stem cell research \nA central activity is the study of adult stem cells\, especially blood‑derived CD34+ cells\, to understand how they behave in normal conditions\, how they transform into leukemic cells\, and how they can be used therapeutically.  IRHT was one of the pioneers showing that purified blood stem cells could regenerate damaged heart muscle after myocardial infarction\, which led to early clinical proof‑of‑concept studies and later to the creation of the spin‑off company CellProthera.[11][5][9][10][12][2] \n## Very small embryonic‑like stem cells and regenerative medicine \nAnother major line of research concerns so‑called very small embryonic‑like stem cells (VSELs)\, rare cells in the adult organism that share properties with embryonic stem cells but can be obtained without destroying embryos.  These cells are investigated as a basis for regenerative medicine\, with clinical work in areas such as myocardial infarction and diabetes\, aiming to repair tissues like the heart or pancreas using ethically acceptable stem‑cell sources.[13][2][11] \n## Leukemia\, cancer and new axes (e.g. brain tumors) \nIRHT also studies how normal stem cells become leukemic\, focusing on mechanisms of transformation that may lead to better diagnostics or targeted therapies for blood cancers.  More recently\, the institute has opened a research axis on brain cancers\, alongside its historical work on hematological malignancies and transplantation\, expanding its cancer‑oriented projects.[14][9][12][2][13] \n## Local integration and collaborations \nThe institute is physically embedded in the Mulhouse hospital and maintains close links with clinical departments\, which facilitates access to patients and samples for translational research.  It collaborates with universities and research teams in France and abroad—including partners in Paris\, the Netherlands\, Germany\, Israel\, North America—and has a formal cooperation framework with the University of Haute‑Alsace for research\, teaching and scientific outreach.
URL:https://www.is2m.uha.fr/event/romain-barbet-institut-de-recherche-en-hematologie-et-transplantation-mulhouse/
LOCATION:Amphithéâtre de l’IS2M\, 15 rue jean starcky\, Mulhouse\, Mulhouse\, 68057\, France
ATTACH;FMTTYPE=image/png:https://www.is2m.uha.fr/wp-content/uploads/2026/01/image694.png
END:VEVENT
END:VCALENDAR